MaxisIT Unveils Site Copilot for Streamlining Clinical Trial Workflows

MaxisIT, a leader in AI-powered clinical trial technologies, today announced the release of Site Copilot, the latest innovation built on the cutting-edge DTect AI platform under MaxisIT's Agentic AI suite. Site Copilot is a conversational AI agent designed to address critical challenges faced by clinical trial sites, such as regulatory compliance, quality management, and patient engagement, while streamlining workflows and improving sponsor-site collaboration.

Although eConsent, eSource, Patient engagement tools, eISF and eTMF are increasingly adopted, the workflow remains broken due to siloed systems. These fragmented workflows create inefficiencies, slower responses to compliance issues, and risks in data quality and patient engagement. Site Copilot seamlessly integrates into workflows without any additional technology burden, empowering staff with actionable insights and recommendations through natural language conversations.

Site Copilot Features:
● Detects and reports anomalous data, trends, events, risks, and actions in the clinical research workflow.
● Recommends the next best action to rectify such anomalies, mitigate risks and improve outcomes by keeping human-in-the-loop.
● Calculates overall "Quality Score" and "Risk Score" of the site by continuously assessing evolving scenarios on an autonomous basis.
● Drives more accurate and reliable results by reducing the risk of incorrect conclusions and transitioning to hybrid workflows managed by AI and AI-augmented site staff.

Source:

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.